ATE247975T1 - Therapeutische mittel für störung des fettstoffwechsels - Google Patents

Therapeutische mittel für störung des fettstoffwechsels

Info

Publication number
ATE247975T1
ATE247975T1 AT95942270T AT95942270T ATE247975T1 AT E247975 T1 ATE247975 T1 AT E247975T1 AT 95942270 T AT95942270 T AT 95942270T AT 95942270 T AT95942270 T AT 95942270T AT E247975 T1 ATE247975 T1 AT E247975T1
Authority
AT
Austria
Prior art keywords
disorder
therapeutic agent
present
lipid metabolism
hypolipidemia
Prior art date
Application number
AT95942270T
Other languages
English (en)
Inventor
Akira Shiota
Nobuaki Fujise
Hiroaki Masunaga
Kanji Higashio
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE247975T1 publication Critical patent/ATE247975T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT95942270T 1994-12-27 1995-12-27 Therapeutische mittel für störung des fettstoffwechsels ATE247975T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6337884A JPH08176007A (ja) 1994-12-27 1994-12-27 脂質代謝異常治療剤
PCT/JP1995/002707 WO1996020004A1 (en) 1994-12-27 1995-12-27 Therapeutic agent for disorder of lipid metabolism

Publications (1)

Publication Number Publication Date
ATE247975T1 true ATE247975T1 (de) 2003-09-15

Family

ID=18312906

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95942270T ATE247975T1 (de) 1994-12-27 1995-12-27 Therapeutische mittel für störung des fettstoffwechsels

Country Status (16)

Country Link
EP (1) EP0754051B1 (de)
JP (1) JPH08176007A (de)
KR (1) KR100395695B1 (de)
AT (1) ATE247975T1 (de)
AU (1) AU710513B2 (de)
CA (1) CA2184248A1 (de)
DE (1) DE69531608T2 (de)
DK (1) DK0754051T3 (de)
ES (1) ES2201128T3 (de)
FI (1) FI115826B (de)
HU (1) HU220139B (de)
NO (1) NO318099B1 (de)
NZ (1) NZ298141A (de)
TW (1) TW480173B (de)
WO (1) WO1996020004A1 (de)
ZA (1) ZA9510981B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
DK0950416T3 (da) 1997-03-14 2007-02-26 Daiichi Seiyaku Co Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse
KR100568664B1 (ko) * 1997-03-14 2006-06-13 다이이치세이야꾸 가부시끼가이샤 악액질 예방 및/또는 치료제
AU6748198A (en) * 1997-04-11 1998-11-11 Takeda Chemical Industries Ltd. Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
ES2276409T3 (es) * 1992-07-16 2007-06-16 Daiichi Pharmaceutical Co., Ltd. Composicion medica que contiene tcf-ii.

Also Published As

Publication number Publication date
FI963312A0 (fi) 1996-08-26
HU220139B (hu) 2001-11-28
KR970701058A (ko) 1997-03-17
TW480173B (en) 2002-03-21
HUT76085A (en) 1997-06-30
FI963312L (fi) 1996-08-26
DE69531608D1 (de) 2003-10-02
DE69531608T2 (de) 2004-02-19
CA2184248A1 (en) 1996-07-04
NO963551L (no) 1996-10-25
HU9602341D0 (en) 1996-10-28
KR100395695B1 (ko) 2004-02-14
WO1996020004A1 (en) 1996-07-04
NZ298141A (en) 2000-12-22
NO318099B1 (no) 2005-01-31
AU4355096A (en) 1996-07-19
ES2201128T3 (es) 2004-03-16
AU710513B2 (en) 1999-09-23
ZA9510981B (en) 1996-07-17
FI115826B (fi) 2005-07-29
DK0754051T3 (da) 2003-09-29
EP0754051A1 (de) 1997-01-22
NO963551D0 (no) 1996-08-26
EP0754051B1 (de) 2003-08-27
JPH08176007A (ja) 1996-07-09

Similar Documents

Publication Publication Date Title
BRPI0413326A (pt) métodos para tratar doença cardiovasculares empregando-se uma molécula ctla4 solúvel
TR200300594T2 (tr) Plazma lipoprotein(a)'yı ve kardiyovasküler hastalıkların risk faktörlerini azaltmak için terkipler ve yöntemler
BR0013122A (pt) Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
NZ503963A (en) 1-substituted-1-aminomethyl-cycloalkane derivatives, or gabapentin analogues, preparation and use in the treatment of neurological disorders
EA200701229A1 (ru) Омега-3 жирные кислоты и дислипидемический агент для липидной терапии
IL160643A0 (en) Combination dosage form containing a cholesterol lowering agent, a renin-angiotensin inhibitor, and aspirin
BR0007556A (pt) Antagonistas de tweak e de receptor de tweak e uso dos mesmos para tratar distúrbios imunológicos
ES2053198T3 (es) Sistema de suministro de un farmaco de glucano y adyuvante.
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
SG127739A1 (en) Use of immuno-regulators
ATE247975T1 (de) Therapeutische mittel für störung des fettstoffwechsels
DK1035859T3 (da) Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler
PT1007055E (pt) Utilizacao de amifostina
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
RU98116126A (ru) Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний
SE0202886L (sv) Dermatologisk användning och dermatologisk beredning
DE69841573D1 (de) Verfahren zur erhöhung der magnesiumabsorption und verhinderung von artheriosklerose
DE602005026394D1 (de) Therapeutische kombinationen
PT888330E (pt) Metodos de tratamento ou prevencao de cistite intersticial
PL368572A1 (en) Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
WO2000051632A3 (de) Kupferagonist, der an die amyloid precursorprotein (app) bindet und/oder eine hemmende wirkung auf die amyloid-a beta-peptids ausübt
BR9709223A (pt) Estimulação dos mecanismos de defesa do hospedeiro contra tumores.
BR9611912A (pt) Composições compreendendo bismuto e um ou mais antimicrobianos para a prevenção e tratamento de distúrbios gastrintestinais
Palazzi et al. Superficial calcinosis related to bleeding in a patient with undifferentiated connective tissue disease and primary biliary cirrhosis
NO20080464L (no) Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0754051

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee